kentucky glp-1 pancreatitis legal team in Role of pancreatic lipase inhibition in obesity treatment: mechanisms and challenges towards current insights and future directions-camerecole A few patients have asked

The MHRA update also complements the recent consensus statement from anaesthetic and specialist organisations that provides guidance for how the increased risk can be managed safely in the perioperative period. In early January 2025, the Association of Anaesthetists published a multidisciplinary consensus statement on elective peri-operative management of adults taking GLP-1 and dual GIP/GLP-1 RAs, which advised that patients take GLP-1 or dual GIP/GLP-1 RAs as normal, as well as receive a full risk assessment and peri-operative techniques to mitigate risk of pulmonary aspiration during the peri-operative period

Portion control is key

As with any medication, there are possible side effects associated with semaglutide

Sometimes a medication prescribed primarily for diabetes, but containing the same active ingredient as a weight loss drug, may be covered

Oral semaglutide requires daily dosing on an empty stomach with strict timing and food restrictions, making it less convenient for most patients

Patients must demonstrate commitment to lifestyle modification for treatment to be initiated and continued